66 results
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
DRUG CLASS, ADVERSE ... #Antianginal #Medications ... #Cardiology #Pharmacology ... #Management #Therapy
Immediate Treatment for Myocardial infraction
#management #pharmacology #medications #treatment #cardiology #mnemonic
Myocardial infraction #management ... #pharmacology # ... medications #treatment ... #cardiology #mnemonic
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
Analgesia and Sedation Medications ... #management ... treatment #sarscov2 #criticalcare ... #coronavirus #medications ... sedative #analgesia #pharmacology
Causes of Drug-Induced Cardiomyopathies

#DrugInduced #Medications #Cardiomyopathy #Cardiomyopathies #Differential #Causes #Cardiology #Pharmacology
#DrugInduced #Medications ... Cardiomyopathies #Differential ... #Causes #Cardiology ... #Pharmacology
NSAIDs and GI versus CV risk

Follow www.instagram.com/rxnotes for more!

#pharmacology #comparison #cardiology #gi #nsaids #pain #medications #management
#pharmacology #comparison ... #cardiology #gi ... #nsaids #pain #medications ... #management #riskfactors
Warfarin color-coded tablets, initial dosing and INR targets

#pharmacology #overview #review #medications #drugs #cardiology #warfarin #management
INR targets #pharmacology ... overview #review #medications ... #drugs #cardiology ... #warfarin #management
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
Over-anticoagulation can lead to severe ... #management #algorithm ... #pharmacology # ... treatment #medications ... #decisionaid #cardiology
Massive Hemoptysis - Differential Diagnosis Framework and Management
Definition: 150-600 mL over 24 hours
Differential Diagnosis:
 • Tracheobronchial:
Massive Hemoptysis - Differential ... over 24 hours Differential ... : 1) Indications ... Coagulopathy 4) Reverse ... #pulmonary #criticalcare
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
Risk Factors for Severe ... COVID-19 Specific Medications ... #COVID19 #ICU #criticalcare ... NonIntensivist #diagnosis #management
High yield pharmacology notes
#pharmacology #cardiology #management #medications #criticalcare #treatment
High yield pharmacology ... notes #pharmacology ... #cardiology #management ... #medications #criticalcare